Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Sep 16, 2021

32601_dirs_2021-09-15_f8b2fd58-9db4-4be9-b95f-e49e8820beb6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-09-14

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-14 Common Stock S 781 $73.359 Disposed 161852 Indirect
2021-09-14 Common Stock S 472 $74.647 Disposed 161380 Indirect
2021-09-14 Common Stock S 227 $75.691 Disposed 161153 Indirect
2021-09-14 Common Stock S 186 $76.425 Disposed 160967 Indirect
2021-09-14 Common Stock S 781 $73.359 Disposed 149251 Indirect
2021-09-14 Common Stock S 473 $74.647 Disposed 148778 Indirect
2021-09-14 Common Stock S 227 $75.691 Disposed 148551 Indirect
2021-09-14 Common Stock S 186 $76.425 Disposed 148365 Indirect

Footnotes

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by DJM Grantor Retained Annuity Trust No. 1, The Maetzold Descendants 2020 Trust, and the Derek Maetzold 2020 Irrevocable Trust on June 15, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $73.050 to $73.940, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: These transactions are a continuation of the transactions reported on a Form 4 filed contemporaneously herewith.

F4: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

F5: This transaction was executed in multiple trades at prices ranging from $74.100 to $75.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $75.105 to $76.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $76.300 to $76.630, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.